BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.810
-0.020 (-1.09%)
At close: Mar 28, 2025, 4:00 PM
1.822
+0.012 (0.65%)
After-hours: Mar 28, 2025, 7:56 PM EDT
BioRestorative Therapies Employees
BioRestorative Therapies had 11 employees as of December 31, 2023. The number of employees increased by 1 or 10.00% compared to the previous year.
Employees
11
Change (1Y)
1
Growth (1Y)
10.00%
Revenue / Employee
$36,455
Profits / Employee
-$816,307
Market Cap
12.53M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BRTX News
- 3 days ago - BioRestorative Therapies, Inc. (BRTX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain - GlobeNewsWire
- 4 weeks ago - BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update - GlobeNewsWire
- 5 weeks ago - BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program - GlobeNewsWire
- 4 months ago - BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program - GlobeNewsWire
- 4 months ago - BioRestorative Therapies, Inc. (BRTX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health - GlobeNewsWire
- 6 months ago - BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire